home / stock / lexx / lexx short
Short Information | Lexaria Bioscience Corp. (NASDAQ:LEXX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 435,021 |
Total Actual Volume | 3,836,739 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 21,751 |
Average Short Percentage | 11.52% |
Is there a LEXX Short Squeeze or Breakout about to happen?
See the LEXX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-26-2024 | $2.17 | $2.35 | $2.45 | $2.17 | 172,105 | 11,754 | 6.83% |
04-25-2024 | $2.15 | $2.19 | $2.3 | $2.15 | 22,122 | 4,196 | 18.97% |
04-24-2024 | $2.2 | $2.2 | $2.28 | $2.18 | 97,910 | 6,221 | 6.35% |
04-23-2024 | $2.24 | $2.24 | $2.3 | $2.2 | 53,982 | 5,039 | 9.33% |
04-22-2024 | $2.19 | $2.265 | $2.29 | $2.19 | 34,458 | 4,173 | 12.11% |
04-19-2024 | $2.26 | $2.2 | $2.29 | $2.15 | 61,647 | 5,502 | 8.93% |
04-18-2024 | $2.34 | $2.25 | $2.41 | $2.22 | 124,708 | 10,208 | 8.19% |
04-17-2024 | $2.3 | $2.34 | $2.73 | $2.25 | 461,093 | 59,983 | 13.01% |
04-16-2024 | $1.98 | $2.31 | $2.35 | $1.85 | 306,531 | 63,275 | 20.64% |
04-15-2024 | $2.12 | $1.99 | $2.14 | $1.91 | 315,206 | 27,019 | 8.57% |
04-12-2024 | $2.64 | $2.12 | $2.64 | $2.12 | 456,031 | 23,804 | 5.22% |
04-11-2024 | $2.6 | $2.51 | $2.72 | $2.5 | 249,700 | 52,236 | 20.92% |
04-10-2024 | $2.65 | $2.66 | $2.79 | $2.6 | 143,405 | 26,755 | 18.66% |
04-09-2024 | $3.03 | $2.7 | $3.03 | $2.64 | 246,969 | 36,208 | 14.66% |
04-08-2024 | $3.18 | $2.96 | $3.18 | $2.93 | 155,258 | 18,332 | 11.81% |
04-05-2024 | $3.12 | $3.05 | $3.29 | $3.05 | 124,644 | 6,842 | 5.49% |
04-04-2024 | $3.29 | $3.19 | $3.48 | $3.17 | 270,527 | 16,124 | 5.96% |
04-03-2024 | $3.38 | $3.41 | $3.5694 | $3.23 | 246,703 | 15,513 | 6.29% |
04-02-2024 | $3.36 | $3.47 | $3.5 | $3.32 | 134,543 | 18,464 | 13.72% |
04-01-2024 | $3.82 | $3.42 | $3.82 | $3.25 | 159,197 | 23,373 | 14.68% |
News, Short Squeeze, Breakout and More Instantly...
Lexaria Bioscience Corp. Company Name:
LEXX Stock Symbol:
NASDAQ Market:
Lexaria, a global innovator in drug delivery platforms, has received approval for its GLP-1 human pilot study #2 by an independent third-party ethics review board GLP-1 drugs are utilized in the treatment of type 2 diabetes and obesity, a huge market, and are typically administered by painful a...
Lexaria, a global innovator in drug delivery platforms, has added three new patents to its portfolio, bringing the total to 41 Two patents were awarded in the U.S., while the third was awarded in Japan, expiring in 2042 and 2041, respectively, if not extended Lexaria’s management plans...
(TheNewswire) Human Pilot Study #2 (GLP-1-H24-2) Approved Kelowna, British Columbia – TheNewswire – April 16, 2024 – Lexaria Bioscience Corp. (Nasdaq: LEXX; LEXXW) (the “Company” or “Lexaria”), a global innovator in drug d...